Effectiveness, tolerability and quality of life in the management of chronic pain unrelated to cancer with sustained-release tramadol administered in a single daily dose;Efectividad, tolerabilidad y calidad de vida en el tratamiento del color crónico no oncológico, con tramadol de liberación controlada en dosis única diaria

Revista de la Sociedad Espanola del Dolor

Volumn 11, Issue 3, 2004, Pages 129-140

  Casals, Miquel ^a   Samper, D ^b  

^a Unidad de Dolor Crónico   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Analgesics; Chronic pain; Controlled release tramadol; Tolerability

Indexed keywords

TRAMADOL; ZYTRAM;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ANOREXIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; CANCER; CHRONIC PAIN; CONSTIPATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOARTHRITIS; PAIN ASSESSMENT; PHARMACOEPIDEMIOLOGY; QUALITY OF LIFE; SIDE EFFECT; SLEEP; SOMNOLENCE; STOMACH PAIN; SUSTAINED RELEASE PREPARATION; SWEATING; VERTIGO; VOMITING; XEROSTOMIA;

EID: 3042842169     PISSN: 11348046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pavelka K. Treatment of pain in osteoarthritis. Eur J Pain 2000; 4 (Supl. A): 23-30.
2. Cossmann M, Kohnen C, Langford R, Mc Cartney C. Tolerance and safety of tramadol use: results of international studies and data from drugs surveillance. Drugs 1997; 53 (Supl. 2) 50-62.
3. Radbruch L, Grond S, Lehmann KA. A risk-benefit assestment of tramadol in the management of pain. Drug Saf 1996; 15: 8-29.
4. Jensen EM, Ginsberg F. Tramadol versus dextropropoxyphene in the treatment of osteoarthritis. Drug Invest 1994; 8: 211-8.
5. Cossman M, Kohnen C. General Tolerability and adverse event profile of tramadol hydrochloride. Rev Contemp Pharmacolther 1995; 6: 513-31.
6. Le Roux PJ, Coetzee JF. Tramadol today. Curr Opin Anaesthesiol 2000; 13: 457-61.
7. Shipton EA. Tramadol Present and future. Anaesth Intensive Care 2000; 28: 363-74.
8. Osipova NA, Novikow GA, Beresnev VA, et al. Analgesic effect of tramadol in cancer patients with chronic pain: a comparison with prolonged action morphine sulphate. Curr Ther Res 1991; 50: 812-21.
9. Tawfick MO, Elborolossy K, Nasr R. Tramadol hidrochloridre in the relief of cancer pain: a double blind comparision against sustained release morphine. Pain 1990; 41 (Supl.). 5: S 377.
10. Bamigbade TA, Langford RM. The clinical use of tramadol hydrochloridre. Pain Reviews 1998; 5: 155-82.
11. Serra J. Tratamiento del dolor neuropático. Es necesario un paso adelante. Rev Soc Esp Dolor 2002; 9: 59-60.
12. Sandor PS, Schoenen J. Migraña. Rev Soc Esp Dolor 2002; 9: 31-6.
13. Carrasco de la Peña JL, Moreno A, Reig E. Estudio de utilidad terapéutica y calidad de vida en pacientes con dolor moderado-severo tratados con tramadol. Informe CIBEST. Centro de Investigación y Bioestadística, 1997.
14. Bodalia B, McDonald CJ, Smith KJ, O'Brien C, Cousens L. A comparison of the pharmacokinetics, clinical efficacy, and tolerabilyti of once-daily tramadol tablets with normal release tramadol capsules. J Pain Symptom Manage 2003; 25: 142-9.
15. Alder L, McDonald C, O'Brien C, Wilson M. A comparison of once-day tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J Rheumatol 2002; 29: 2196-9.
16. Katz WA. Pharmacology and clinical experience with tramadol in osteoartthritis. Drugs 1996; 52 (Supl. 3): 39-47.
17. Raber M, Hofmann S, Junge K, Momberger H, Kuhn D. Eficacia analgesica y tolerabilidad de tramadol 100 mg en capsulas de liberación retardada en pacientes con dolor lumbar cónico de moderado a intenso. Clin Drug Invest 1999; 6: 417-24.
18. Price PM, Budd K. Tramadol in treatment of spinal pain: a short report based on the results of a survey of 50 patients. B J Med Econ 1995; 9: 17-20.
19. Sorje J, Stadler TH. Comparison of the analgesic eficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronyc low back pain. Clin Drug Invest 1997; 14: 157-64.
20. Lee Cr, Mc Tavish D, Sorkin FM. Tramadol a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potencial in acute and chronic pain status, Drugs 1993; 46: 113-40.
21. Besson JM. Apport de tramadol dans le strategie therapeutique de la dolulencia. Drugs 1997; 53 (Supl. 2): 63-4.
22. Williams HJ. Clorhidrato de tramadol: algo nuevo en la terapia analgésica oral. Curr Ther Res. Ed Española 1997; 58 n°11.
23. Cossman M, Wilsmann KM. Effect and side effects of tramadol: an open phase IV study with 7198 patients. Therapiewoche 1987; 37: 3475-85.
24. Anónimo. Eficacia analgésica. Zytram ® una dosis al día un día sin dolor. Publicaciones Zambón Group, 2000. p. 51-67.
25. Oliva P, Carbonell R, Giróm JA, et al. Opiáceos orales de liberación retardada: tramadol versus dihidrocodeína en dolor tumoral crónico por cáncer de próstata. Rev Soc Esp Dolor 2000; 7: 285-90.
26. O'Reilly SC, Muir KR, Doherty M. Knee pain ad disability in the Nottingham community; association with poor healt status and psychological distress. Br J Rheumatol 1998; 37: 870-3.
27. Dalgin PH. Use of tramadol in in chronic pain. Clin Geriatr 1995; 3: 17-30.
28. Grond S, Zech D, Lynch J, et al. Tramadol a weack opioid for relief of cancer pain. Pain Clin 1992; 5: 241-8.